<DOC>
	<DOCNO>NCT00762164</DOCNO>
	<brief_summary>The purpose study compare efficacy Vytorin 10/80 tablet , approve agent treatment elevate LDL cholesterol combine cholesterol absorption inhibitor Ezetimibe 10 mg simvastatin 80 mg , split 4 use tablet splitter , versus whole simvastatin 20 milligram tablet .</brief_summary>
	<brief_title>Comparison Effect Vytorin 10/80 Tablet Split Into 4 Simvastatin 20 Milligrams Low-density Lipoprotein ( LDL ) Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>Subjects LDLcholesterol great 100 mg/dL Patients willing able provide sign informed consent Patients receive statin ( Lipitor , Crestor , Lescol , Simvastatin , Pravachol ) Patients intolerant statin Patients receive ezetimibe Patients intolerant ezetimibe Patients receive niacin preparation Stroke , TIA , myocardial infarction , unstable angina , percutaneous coronary intervention , coronary artery bypass surgery , major surgery within 3 month Cancer undergo active treatment Creatinine clearance &lt; 50 ml/minute Active liver disease persistent elevation SGOT SGPT &gt; 2 time upper limit normal level Participation clinical study within last 30 day Drug addition alcohol abuse within past 6 month Use azole antifungal agent , amiodarone , fibrates immunosuppressant drug within last 3 month Active use macrolide antibiotic verapamil Consumption grapefruit juice daily basis Patients unwilling unable provide inform consent Patients poor compliance Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Hypercholesterolemia</keyword>
	<keyword>Statins</keyword>
	<keyword>Ezetimibe</keyword>
</DOC>